The Change of CD4+CD25+Foxp3+regulatory T Cells in Peripheral Blood of Patients with Graves Disease Treated by Iodine-131

ZHA Bing-Bing,LIU Jun,ZHA Ying,WANG Fang,SHENG Li,DING He-Yuan,CHEN Zhao-Ping,XU Jiong

DOI: https://doi.org/10.3969/j.issn.1000-484x.2012.11.016

2012-01-01

Abstract:Objective:To explore whether 131I reverted the immune disorder of Graves′ disease(GD) via changing the proportion of CD4+CD25+ Foxp3+ regulatory T cells(Tregs),we evaluated the peripheral lymphocyte subsets,Tregs and the expression of Foxp3 mRNA from GD patients before 131I administration and in the first month after 131I administration.Methods:Thirty GD patients treated by 131I were included in this study.The proportion of lymphocyte subsets in the peripheral blood from GD before 131I administration and in the first month after 131I administration were detected by flow cytometric analysis.Real-time polymerase chain reaction was performed also to measure the expression of Foxp3mRNA.Results:Compared to GD patients before 131I administration,the proportion of CD3-CD19+ B and CD3+CD4+T lymphocytes was significantly lower(P0.05),and the proportion of CD3-CD16+CD56+NK lymphocytes was significantly higher in GD patients in the first month after 131I administration(P0.05),the proportion of CD3-CD8+ T lymphocytes,Tregs and the expression of Foxp3mRNA could not be changed remarkably.Conclusion:Iodine-131 might not alleviate impairment of immunological tolerance via increasing the proportion of Tregs,while it might control excessive immunological response via decreasing the proportion of CD3-CD19+ B and CD3+CD4+T lymphocytes and increasing the proportion of NK lymphocytes.